Dr. Bijoy Menon Presents at European Stroke Conference

13 May 2022 10:22 AM | Anonymous

The AcT trial was a large RCT that sought to find if intravenous tenecteplase can replace alteplase in the treatment of patients with acute ischemic stroke presenting early after stroke onset. The findings were presented by Bijoy K Menon MBBS, M.D, D.M, MSc, FRCPC at the European Stroke Conference in Lyon, France.

Powered by Wild Apricot Membership Software